|
|
Volumn 97, Issue 4, 2008, Pages 330-339
|
|
Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults
|
|
Author keywords
Giant cell; Leiomyosarcoma; Liposarcoma; Malignant fibrous histiocytoma; Myxofibrosarcoma; Pleomorphic sarcoma; Rhabdomyosarcoma
|
|
Indexed keywords
DOXORUBICIN;
EPIRUBICIN;
IFOSFAMIDE;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CELL DIFFERENTIATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
CYTOGENETICS;
DRUG MEGADOSE;
FIBROMYXOSARCOMA;
GIANT CELL;
GIANT CELL TUMOR;
HUMAN;
MALIGNANT FIBROUS HISTIOCYTOMA;
MOLECULAR GENETICS;
PATHOLOGIST;
PLEOMORPHIC SARCOMA;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
SOFT TISSUE TUMOR;
TREATMENT OUTCOME;
TUMOR CLASSIFICATION;
TUMOR DIFFERENTIATION;
ADULT;
COMBINED MODALITY THERAPY;
DIAGNOSIS, DIFFERENTIAL;
HISTIOCYTOMA, MALIGNANT FIBROUS;
HUMANS;
LEIOMYOSARCOMA;
LIPOSARCOMA;
PROGNOSIS;
SARCOMA;
|
|
EID: 40549134987
PISSN: 00224790
EISSN: 10969098
Source Type: Journal
DOI: 10.1002/jso.20972 Document Type: Review |
|
Times cited : (98)
|
|
References (96)
|
